Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of mucinous BOTs, appendectomy should be perfo...

background: sarcoma botryoides of cervix is a rare variant of rhabdomyosarcomas (rms) of female genital tract. it is usually diagnosed in first or second decade of life. in this case report, we aimed to present a 21 year-old nulligravid patient who was diagnosed with embryonal rms of the cervix, to discuss the treatment options that have been stated in the literature, and to highlight the advan...

OBJECTIVE To report experience with borderline ovarian tumors (BOTs) in a developing country like Pakistan with limited resources and weak database of health system. METHODS Patients with BOTs managed at Shaukat Khanum Cancer hospital, Lahore, Pakistan from 2004 to 2014 were included and reviewed retrospectively. Data was recorded on histopathological types, age, CA-125, stage of disease, tre...

The aim of this review is to present an overview of available methods for preservation of ovarian function and fertility in female cancer patients who desire to maintain their child-bearing capacity for future pregnancies. A Medline search was conducted. Published articles from American and European studies from 1976 to present were reviewed. The effect of cancer treatment on the ovary, as well...

PURPOSE: The Breast Reconstruction Risk Assessment (BRA) Score is a model developed to predict the risk of surgical site infections (SSI) within 30 days after breast reconstruction. This was derived from the National Surgical Quality Improvement Program (NSQIP) database, where the average risk of SSI was 3.75%. We aim to externally validate this model in our cohort of patients who have undergon...